Expression of corticosteroid-regulated genes by PBMCs in children with asthma

Elena Goleva, Denise C. Babineau, Michelle A. Gill, Leisa P. Jackson, Baomei Shao, Zheng Hu, Andrew H. Liu, Cynthia M. Visness, Christine A. Sorkness, Donald Y.M. Leung, Alkis Togias, William W. Busse

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Variability in response to inhaled corticosteroids (ICSs) can result in less than optimal asthma control. Development of biomarkers assessing the therapeutic efficacy of corticosteroids is important. Objective: We sought to examine whether in vitro PBMC responses to corticosteroids relate to the clinical ICS response. Methods: PBMCs were collected from 125 children with asthma (6-17 years) at enrollment (visit 0 [V0]) and after 1 year of bimonthly guidelines-based management visits (visit 6 [V6]). Difficult-to-control and easy-to-control asthma were defined as requiring daily therapy with 500 μg or more of fluticasone propionate (FLU) with or without a long-acting β-agonist versus 100 μg or less of FLU in at least 4 visits. mRNA levels of glucocorticoid receptor α and corticosteroid transactivation (FK506-binding protein 5) and transrepression markers (IL-8 and TNF-α) were measured by using RT-PCR in freshly isolated cells and in response to 10−8 mol/L FLU. Results: Compared with PBMCs from patients with easy-to-control asthma, PBMCs from those with difficult-to-control asthma had significantly lower glucocorticoid receptor α levels at V0 (P =.05). A 30% increase in IL-8 suppression by FLU (P =.04) and a trend for increased TNF-α suppression by FLU between V0 and V6 (P =.07) were observed in patients with easy-to-control asthma. In contrast, no changes between V0 and V6 in IL-8 and TNF-α suppression by FLU were observed in patients with difficult-to-control asthma. Corticosteroid-mediated transactivation (FK506-binding protein 5 induction by FLU) increased in the PBMCs of patients with difficult-to-control and easy-to-control asthma between V0 and V6 (P =.05 and P =.03, respectively). Conclusions: PBMCs of children with difficult-to-control asthma treated with guidelines-based therapy and requiring high-dose ICSs had reduced in vitro responsiveness to corticosteroids.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Adrenal Cortex Hormones
Asthma
Genes
Interleukin-8
Glucocorticoid Receptors
Transcriptional Activation
Guidelines
Fluticasone
Therapeutics
Biomarkers
Polymerase Chain Reaction
Messenger RNA

Keywords

  • Asthma
  • corticosteroids
  • glucocorticoid receptor
  • steroid resistance

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Expression of corticosteroid-regulated genes by PBMCs in children with asthma. / Goleva, Elena; Babineau, Denise C.; Gill, Michelle A.; Jackson, Leisa P.; Shao, Baomei; Hu, Zheng; Liu, Andrew H.; Visness, Cynthia M.; Sorkness, Christine A.; Leung, Donald Y.M.; Togias, Alkis; Busse, William W.

In: Journal of Allergy and Clinical Immunology, 01.01.2018.

Research output: Contribution to journalArticle

Goleva, E, Babineau, DC, Gill, MA, Jackson, LP, Shao, B, Hu, Z, Liu, AH, Visness, CM, Sorkness, CA, Leung, DYM, Togias, A & Busse, WW 2018, 'Expression of corticosteroid-regulated genes by PBMCs in children with asthma', Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2018.06.043
Goleva, Elena ; Babineau, Denise C. ; Gill, Michelle A. ; Jackson, Leisa P. ; Shao, Baomei ; Hu, Zheng ; Liu, Andrew H. ; Visness, Cynthia M. ; Sorkness, Christine A. ; Leung, Donald Y.M. ; Togias, Alkis ; Busse, William W. / Expression of corticosteroid-regulated genes by PBMCs in children with asthma. In: Journal of Allergy and Clinical Immunology. 2018.
@article{960cee88925e4769bfb7a55e7d6bc6d6,
title = "Expression of corticosteroid-regulated genes by PBMCs in children with asthma",
abstract = "Background: Variability in response to inhaled corticosteroids (ICSs) can result in less than optimal asthma control. Development of biomarkers assessing the therapeutic efficacy of corticosteroids is important. Objective: We sought to examine whether in vitro PBMC responses to corticosteroids relate to the clinical ICS response. Methods: PBMCs were collected from 125 children with asthma (6-17 years) at enrollment (visit 0 [V0]) and after 1 year of bimonthly guidelines-based management visits (visit 6 [V6]). Difficult-to-control and easy-to-control asthma were defined as requiring daily therapy with 500 μg or more of fluticasone propionate (FLU) with or without a long-acting β-agonist versus 100 μg or less of FLU in at least 4 visits. mRNA levels of glucocorticoid receptor α and corticosteroid transactivation (FK506-binding protein 5) and transrepression markers (IL-8 and TNF-α) were measured by using RT-PCR in freshly isolated cells and in response to 10−8 mol/L FLU. Results: Compared with PBMCs from patients with easy-to-control asthma, PBMCs from those with difficult-to-control asthma had significantly lower glucocorticoid receptor α levels at V0 (P =.05). A 30{\%} increase in IL-8 suppression by FLU (P =.04) and a trend for increased TNF-α suppression by FLU between V0 and V6 (P =.07) were observed in patients with easy-to-control asthma. In contrast, no changes between V0 and V6 in IL-8 and TNF-α suppression by FLU were observed in patients with difficult-to-control asthma. Corticosteroid-mediated transactivation (FK506-binding protein 5 induction by FLU) increased in the PBMCs of patients with difficult-to-control and easy-to-control asthma between V0 and V6 (P =.05 and P =.03, respectively). Conclusions: PBMCs of children with difficult-to-control asthma treated with guidelines-based therapy and requiring high-dose ICSs had reduced in vitro responsiveness to corticosteroids.",
keywords = "Asthma, corticosteroids, glucocorticoid receptor, steroid resistance",
author = "Elena Goleva and Babineau, {Denise C.} and Gill, {Michelle A.} and Jackson, {Leisa P.} and Baomei Shao and Zheng Hu and Liu, {Andrew H.} and Visness, {Cynthia M.} and Sorkness, {Christine A.} and Leung, {Donald Y.M.} and Alkis Togias and Busse, {William W.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jaci.2018.06.043",
language = "English (US)",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Expression of corticosteroid-regulated genes by PBMCs in children with asthma

AU - Goleva, Elena

AU - Babineau, Denise C.

AU - Gill, Michelle A.

AU - Jackson, Leisa P.

AU - Shao, Baomei

AU - Hu, Zheng

AU - Liu, Andrew H.

AU - Visness, Cynthia M.

AU - Sorkness, Christine A.

AU - Leung, Donald Y.M.

AU - Togias, Alkis

AU - Busse, William W.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Variability in response to inhaled corticosteroids (ICSs) can result in less than optimal asthma control. Development of biomarkers assessing the therapeutic efficacy of corticosteroids is important. Objective: We sought to examine whether in vitro PBMC responses to corticosteroids relate to the clinical ICS response. Methods: PBMCs were collected from 125 children with asthma (6-17 years) at enrollment (visit 0 [V0]) and after 1 year of bimonthly guidelines-based management visits (visit 6 [V6]). Difficult-to-control and easy-to-control asthma were defined as requiring daily therapy with 500 μg or more of fluticasone propionate (FLU) with or without a long-acting β-agonist versus 100 μg or less of FLU in at least 4 visits. mRNA levels of glucocorticoid receptor α and corticosteroid transactivation (FK506-binding protein 5) and transrepression markers (IL-8 and TNF-α) were measured by using RT-PCR in freshly isolated cells and in response to 10−8 mol/L FLU. Results: Compared with PBMCs from patients with easy-to-control asthma, PBMCs from those with difficult-to-control asthma had significantly lower glucocorticoid receptor α levels at V0 (P =.05). A 30% increase in IL-8 suppression by FLU (P =.04) and a trend for increased TNF-α suppression by FLU between V0 and V6 (P =.07) were observed in patients with easy-to-control asthma. In contrast, no changes between V0 and V6 in IL-8 and TNF-α suppression by FLU were observed in patients with difficult-to-control asthma. Corticosteroid-mediated transactivation (FK506-binding protein 5 induction by FLU) increased in the PBMCs of patients with difficult-to-control and easy-to-control asthma between V0 and V6 (P =.05 and P =.03, respectively). Conclusions: PBMCs of children with difficult-to-control asthma treated with guidelines-based therapy and requiring high-dose ICSs had reduced in vitro responsiveness to corticosteroids.

AB - Background: Variability in response to inhaled corticosteroids (ICSs) can result in less than optimal asthma control. Development of biomarkers assessing the therapeutic efficacy of corticosteroids is important. Objective: We sought to examine whether in vitro PBMC responses to corticosteroids relate to the clinical ICS response. Methods: PBMCs were collected from 125 children with asthma (6-17 years) at enrollment (visit 0 [V0]) and after 1 year of bimonthly guidelines-based management visits (visit 6 [V6]). Difficult-to-control and easy-to-control asthma were defined as requiring daily therapy with 500 μg or more of fluticasone propionate (FLU) with or without a long-acting β-agonist versus 100 μg or less of FLU in at least 4 visits. mRNA levels of glucocorticoid receptor α and corticosteroid transactivation (FK506-binding protein 5) and transrepression markers (IL-8 and TNF-α) were measured by using RT-PCR in freshly isolated cells and in response to 10−8 mol/L FLU. Results: Compared with PBMCs from patients with easy-to-control asthma, PBMCs from those with difficult-to-control asthma had significantly lower glucocorticoid receptor α levels at V0 (P =.05). A 30% increase in IL-8 suppression by FLU (P =.04) and a trend for increased TNF-α suppression by FLU between V0 and V6 (P =.07) were observed in patients with easy-to-control asthma. In contrast, no changes between V0 and V6 in IL-8 and TNF-α suppression by FLU were observed in patients with difficult-to-control asthma. Corticosteroid-mediated transactivation (FK506-binding protein 5 induction by FLU) increased in the PBMCs of patients with difficult-to-control and easy-to-control asthma between V0 and V6 (P =.05 and P =.03, respectively). Conclusions: PBMCs of children with difficult-to-control asthma treated with guidelines-based therapy and requiring high-dose ICSs had reduced in vitro responsiveness to corticosteroids.

KW - Asthma

KW - corticosteroids

KW - glucocorticoid receptor

KW - steroid resistance

UR - http://www.scopus.com/inward/record.url?scp=85054421216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054421216&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2018.06.043

DO - 10.1016/j.jaci.2018.06.043

M3 - Article

C2 - 30059697

AN - SCOPUS:85054421216

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

ER -